Newsletter Watch: Omrix Biopharmaceuticals
Bill Martin is well known as the founder of RagingBull.com, one of the earliest and most successful online investor sites. Now, he edits the equally successful BullMarket.com, which offers daily trading and investing advice and is noted for its in-depth research.
Martin recently turned his analysis to Omrix Biopharmaceuticals (Nasdaq:OMRI), a small-cap firm that operates in the biosurgical products and passive immunotherapy markets. The stock has a market capitalization of $261 million.
The company's biosurgical products are used for the control of bleeding, or hemostasis, during surgery along with other surgical applications. Its key products are Evicel, Quixel and Evithrom.
The company has a marketing partnership with Ethicon, Martin says, which is a subsidiary of Johnson & Johnson (NYSE:JNJ). Ethicon handles the marketing and sales of the products, while Omrix focuses on manufacturing and product development.
"Evicel and Quixil are the first, and currently the only, commercially available liquid fibrin sealants that do not contain animal-derived components," he says. Evicel is approved in the United States for use in patients undergoing surgery when the control of bleeding by standard surgical techniques is ineffective or impractical.
The advisor says that Evithrom is the first human thrombin to be approved by the Food & Drug Administration since 1954, and it is the only product currently licensed.
The company's second market is a passive immunotherapy product line that includes products that are used to treat immune deficiencies and infectious diseases, as well as for potential biodefense applications.
It supplies vaccinia immunoglobulin, or VIG, to several governments as a means to treat smallpox vaccine-related complications in the event of a smallpox terrorist attack, according to Martin.
It also markets an intravenous version in Israel, known as IVIG, he says, . . .
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
